September 15, 2021
Stories this photo appears in:
Chances are you probably know someone who is or has been impacted by sickle cell disease (SCD). In fact, 1 in 13 African Americans have the sickle cell trait. While it’s considered a rare genetic disease, it’s actually the most common inherited blood disorder in the world. Every September, we recognize Sickle Cell Awareness Month in the U.S. As we mark the month this year, we’re taking this opportunity to raise awareness about this devastating disease, elevate voices in the community to share their experience living with the disease and highlight potential treatments scientists at Vertex Pharmaceuticals have been working on. Read on to learn more about the underlying cause of SCD and how scientists are currently investigating a potential gene-editing therapy to address this serious disease.